Sana Biotechnology (SANA) Other Non-Current Assets (2020 - 2026)

Sana Biotechnology has reported Other Non-Current Assets for 7 years, with the latest figure at $4.2 million in Q1 2026.

• Quarterly Other Non-Current Assets changed 0.0% year-over-year to $4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (changed 0.0% YoY) and the FY2025 annual result came in at $3.2 million, down 38.04% from the prior year.
• Other Non-Current Assets rose to $4.2 million in Q1 2026 per SANA's latest filing, from $3.2 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $10.5 million in Q2 2022 and troughed at $3.2 million in Q4 2025.
• A 5-year average of $5.4 million and a median of $4.2 million in 2025 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets soared 389.97% in 2022, then plunged 63.81% in 2023.
• Over 5 years, Other Non-Current Assets stood at $10.5 million in 2022, then slumped by 63.81% to $3.8 million in 2023, then surged by 34.76% to $5.1 million in 2024, then plunged by 38.04% to $3.2 million in 2025, then soared by 32.37% to $4.2 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $4.2 million, $3.2 million, and $3.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.